Study: Pfizer and AstraZeneca vaccines ‘highly effective’ against Indian variant

By Christine Fabro

Studies show that Pfizer and AstraZeneca COVID-19 vaccines are two of the most effective vaccines against the B.1.617 strains or the Indian variant after the second dose.

Based on a study by the Public Health England (PHE) between April 5 and May 16, Pfizer-BioNTech vaccine was found to be 88% effective against symptomatic disease from the double mutant variant two weeks after the second dose.

Meanwhile, two doses of the AstraZeneca vaccine were 60% effective against the Indian variant.

The study also found that both vaccines were 33% effective against symptomatic disease from B.1.617, three weeks after the first dose.

Health and Social Care Secretary Matt Hancock said that this new evidence proves the value of COVID-19 vaccination program in protecting people.

PHE’s Head of Immunisation Dr. Mary Ramsay also expects vaccines to be even more effective at preventing death and hospitalization among individuals. –rir

Popular

PBBM to visit Brazil next year after historic talks with Lula

By Ruth Abbey Gita-Carlos  | Philippine News Agency President Ferdinand R. Marcos Jr. will visit Brazil next year following his historic bilateral talks with Brazilian...

PBBM urges biz-gov’t collab, champions youth empowerment in engagements with ASEAN reps

By Dean Aubrey Caratiquet Capping off a day of successive engagements, President Ferdinand R. Marcos Jr. interfaced with representatives from various groups with a focus...

PBBM champions whole-of-ASEAN approach in opening of plenary, retreat sessions

By Dean Aubrey Caratiquet In recognition of the cumulative efforts by delegates to sustain regional progress, President Ferdinand R. Marcos Jr. opened the 49th ASEAN...

Malacañang: PBBM hopeful SCS Code of Conduct will be finalized

By Ruth Abbey Gita-Carlos  | Philippine News Agency President Ferdinand R. Marcos Jr. remains optimistic that negotiations for a Code of Conduct (COC) in the...